Mindset Pharma Inc
CNSX:MSET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zinwell Corporation
TWSE:2485
|
TW |
Mindset Pharma Inc
Research & Development
Mindset Pharma Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mindset Pharma Inc
CNSX:MSET
|
Research & Development
-CA$7.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Research & Development
-$629m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Research & Development
-CA$489k
|
CAGR 3-Years
41%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Research & Development
-$4.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Research & Development
-$105.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-152%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Research & Development
-CA$27.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-26%
|
|
Mindset Pharma Inc
Glance View
Mindset Pharma, Inc. is a pharmaceutical discovery and development company. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-12-23. The firm is focused on developing patentable psychedelic compounds for the treatment of neurological and psychiatric disorders, with an initial focus on psilocybin-inspired new chemical entities (NCEs). Its drug development platform seeks to advance medicines based on psychedelic substances through rigorous scientific and clinical trials, performed by third-party contract research organizations. The firm intends to commercialize the psilocybin-inspired psychedelic medicines that it develops as regulated medicines.
See Also
What is Mindset Pharma Inc's Research & Development?
Research & Development
-7.4m
CAD
Based on the financial report for Jun 30, 2022, Mindset Pharma Inc's Research & Development amounts to -7.4m CAD.
What is Mindset Pharma Inc's Research & Development growth rate?
Research & Development CAGR 1Y
-233%
Over the last year, the Research & Development growth was -233%.
